These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22213327)

  • 1. Influence of calcitriol on prostaglandin- and vitamin D-metabolising enzymes in benign and malignant breast cell lines.
    Thill M; Cordes T; Hoellen F; Becker S; Dittmer C; Kümmel S; Salehin D; Friedrich M; Diedrich K; Köster F
    Anticancer Res; 2012 Jan; 32(1):359-65. PubMed ID: 22213327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin metabolizing enzymes in correlation with vitamin D receptor in benign and malignant breast cell lines.
    Thill M; Fischer D; Becker S; Cordes T; Dittmer C; Diedrich K; Salehin D; Friedrich M
    Anticancer Res; 2009 Sep; 29(9):3619-25. PubMed ID: 19667157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of prostaglandin- and vitamin D-metabolising enzymes in benign and malignant breast cells.
    Thill M; Hoellen F; Becker S; Dittmer C; Fischer D; Kümmel S; Salehin D; Friedrich M; Köster F; Diedrich K; Cordes T
    Anticancer Res; 2012 Jan; 32(1):367-72. PubMed ID: 22213328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of prostaglandin metabolizing enzymes and serum PGE2 levels with vitamin D receptor and serum 25(OH)2D3 levels in breast and ovarian cancer.
    Cordes T; Hoellen F; Dittmer C; Salehin D; Kümmel S; Friedrich M; Köster F; Becker S; Diedrich K; Thill M
    Anticancer Res; 2012 Jan; 32(1):351-7. PubMed ID: 22213326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin metabolising enzymes and PGE2 are inversely correlated with vitamin D receptor and 25(OH)2D3 in breast cancer.
    Thill M; Fischer D; Hoellen F; Kelling K; Dittmer C; Landt S; Salehin D; Diedrich K; Friedrich M; Becker S
    Anticancer Res; 2010 May; 30(5):1673-9. PubMed ID: 20592360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of prostaglandin metabolising enzymes COX-2 and 15-PGDH and VDR in human granulosa cells.
    Thill M; Becker S; Fischer D; Cordes T; Hornemann A; Diedrich K; Salehin D; Friedrich M
    Anticancer Res; 2009 Sep; 29(9):3611-8. PubMed ID: 19667156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment of breast cancer cell lines with vitamin D and COX-2 inhibitors.
    Thill M; Reichert K; Woeste A; Polack S; Fischer D; Hoellen F; Rody A; Friedrich M; Köster F
    Anticancer Res; 2015 Feb; 35(2):1189-95. PubMed ID: 25667510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway.
    Moreno J; Krishnan AV; Peehl DM; Feldman D
    Anticancer Res; 2006; 26(4A):2525-30. PubMed ID: 16886660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
    Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
    Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation.
    Lopes N; Carvalho J; Durães C; Sousa B; Gomes M; Costa JL; Oliveira C; Paredes J; Schmitt F
    Anticancer Res; 2012 Jan; 32(1):249-57. PubMed ID: 22213313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitriol inhibits Ether-à go-go potassium channel expression and cell proliferation in human breast cancer cells.
    García-Becerra R; Díaz L; Camacho J; Barrera D; Ordaz-Rosado D; Morales A; Ortiz CS; Avila E; Bargallo E; Arrecillas M; Halhali A; Larrea F
    Exp Cell Res; 2010 Feb; 316(3):433-42. PubMed ID: 19932096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vitamin D receptor (VDR), cyclooxygenase-2 (COX-2) and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in benign and malignant ovarian tissue and 25-hydroxycholecalciferol (25(OH2)D3) and prostaglandin E2 (PGE2) serum level in ovarian cancer patients.
    Thill M; Fischer D; Kelling K; Hoellen F; Dittmer C; Hornemann A; Salehin D; Diedrich K; Friedrich M; Becker S
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):387-90. PubMed ID: 20304053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.
    Moreno J; Krishnan AV; Swami S; Nonn L; Peehl DM; Feldman D
    Cancer Res; 2005 Sep; 65(17):7917-25. PubMed ID: 16140963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D regulates the phenotype of human breast cancer cells.
    Pendás-Franco N; González-Sancho JM; Suárez Y; Aguilera O; Steinmeyer A; Gamallo C; Berciano MT; Lafarga M; Muñoz A
    Differentiation; 2007 Mar; 75(3):193-207. PubMed ID: 17288543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of VDR-responsive gene signatures in breast cancer cells.
    Towsend K; Trevino V; Falciani F; Stewart PM; Hewison M; Campbell MJ
    Oncology; 2006; 71(1-2):111-23. PubMed ID: 17377416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.
    Elstner E; Linker-Israeli M; Said J; Umiel T; de Vos S; Shintaku IP; Heber D; Binderup L; Uskokovic M; Koeffler HP
    Cancer Res; 1995 Jul; 55(13):2822-30. PubMed ID: 7796409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Combined Treatment with Vitamin D and COX2 Inhibitors on Breast Cancer Cell Lines.
    Friedrich M; Reichert K; Woeste A; Polack S; Fischer D; Hoellen F; Rody A; Köster F; Thill M
    Anticancer Res; 2018 Feb; 38(2):1201-1207. PubMed ID: 29374758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D induced up-regulation of keratinocyte growth factor (FGF-7/KGF) in MCF-7 human breast cancer cells.
    Lyakhovich A; Aksenov N; Pennanen P; Miettinen S; Ahonen MH; Syvälä H; Ylikomi T; Tuohimaa P
    Biochem Biophys Res Commun; 2000 Jul; 273(2):675-80. PubMed ID: 10873663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of MAPK ERK1 and ERK2 in VDR-positive and -negative breast cancer cell lines.
    Cordes T; Diesing D; Becker S; Diedrich K; Reichrath J; Friedrich M
    Anticancer Res; 2006; 26(4A):2749-53. PubMed ID: 16886687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.